StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research report report published on Thursday morning. The firm issued a buy rating on the stock.
Mannatech Stock Down 0.7 %
NASDAQ MTEX traded down $0.06 during trading hours on Thursday, hitting $8.01. The company had a trading volume of 762 shares, compared to its average volume of 475. The firm’s 50 day moving average is $8.48 and its 200 day moving average is $8.70. The company has a quick ratio of 0.51, a current ratio of 1.07 and a debt-to-equity ratio of 0.09. Mannatech has a fifty-two week low of $7.50 and a fifty-two week high of $15.10.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its earnings results on Thursday, March 28th. The company reported ($0.94) earnings per share (EPS) for the quarter. The company had revenue of $32.69 million during the quarter. Mannatech had a negative net margin of 1.70% and a negative return on equity of 19.19%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- How to Start Investing in Real Estate
- MarketBeat Week in Review – 4/29 – 5/3
- How to Find Undervalued Stocks
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Health Care Stocks Explained: Why You Might Want to Invest
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
